S02 Cardiovascular Disease and Diabetes: Focus on Sex Differences

Program: Symposia
Clinical Session
Friday, April 1, 2016: 9:45 AM-11:15 AM
BR East (BCEC)
Chair:
Alice Y Chang, MD, MSc, Mayo Clinic, Rochester, MN

Nothing to Disclose: AYC
9:45 AM
Judith G Regensteiner, PhD, Medicine, University of Colorado School of Medicine, Aurora, CO
Disclosures:
JGR: Principal Investigator, Merck & Co., Principal Investigator, Astra Zeneca.
10:15 AM
Kathryn Marian Rexrode, MD, MPH, Div of Preventive Medicine, Brigham and Women's Hospital, Boston, MA
Nothing to Disclose: KMR
10:45 AM
Sherita Golden, MD, Medicine, Johns Hopkins School of Medicine, Baltimore, MD
Nothing to Disclose: SG
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire